Our newest members
Name Country Date
Thomas J. Musholt Germany 28/06/09
Barbara Planko Switzerland 24/06/09
CHRISTOS BASAGIANNIS Greece 18/06/09
Karen Balstrup Denmark 10/06/09
JOSE LUIS PAZ-IBARRA Peru 06/06/09
Merryn Thomae Australia 04/06/09
Enzo Domenichini Argentina 03/06/09
David Berry United Kingdom 03/06/09
Annual membership fee is EUR 30,-
To pay membership dues, registration fees or to make other payments to ENETS, please click here. We accept the following credit cards:
Mastercard Visa
Home


The 6th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease was held 5-7 March 2009 in Granada, Spain. This international conference was endorsed by the European Accreditation Council for Continuing Medical Education and attracted 1,100 delegates and 120 abstracts, which will be published this summer in Neuroendocrinology.

Please click here to view the conference program. For an overview of the conference, please click here.
The Society, between 2005 and 2007, produced revisions to NET diagnosis and treatment guidelines. The Guidelines today serve clinicians worldwide in managing patient care. Please click here to access the Guidelines and, as well, to view the Society's published work on TNM classifications.
The Benefits of ENETS Membership include
bulletan invitation to the ENETS annual conference (read about past conferences by clicking here)
bulleta reduced subscription fee to the online version of Neuroendocrinology, the official journal of ENETS
bulletreduced-fee or free participation in regular training programs and symposia
bulletregular updates on research results and upcoming events through the ENETS Newsletter
bulletparticipation in multicentered clinical trials
bulletregular updates on advances in diagnosis and therapy
bulletpassword-protected access to the members' section of the ENETS homepage

To become a member, click here
The European Neuroendocrine Tumor Society (ENETS) is an international professional association composed of physicians and researchers, whose main area of study is related to neuroendocrine tumors. It was founded in Frankfurt am Main on 11 March 2004.

Literature
Sponsors